Clinical and immunological manifestations in 151 SLE patients living in Dubai

被引:48
作者
AlSaleh, J. [1 ]
Jassim, V. [1 ]
ElSayed, M. [1 ]
Saleh, N. [1 ]
Harb, D. [1 ]
机构
[1] Dubai Hosp, Dept Med, Dubai, U Arab Emirates
关键词
Arab; autoantibody; Dubai; systemic lupus erythematosus;
D O I
10.1177/0961203307084297
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To gain better understanding of systemic lupus erythematosus (SLE) in Dubai we studied the clinical and immunological manifestations in a cohort of 151 patients attended Rheumatology Clinic in Dubai Hospital between January 2002 and January 2007. We found that the female to male ratio was 20.5: 1, with a mean age of 35.5 years (0.9). The mean age at disease onset was 28.9 years (0.8) and mean disease duration 6.7 years (0.4). Five-year survival rate in our cohort was 94%. The commonest clinical manifestations in this cohort were arthritis (88%), haematological abnormalities (61.6%), and malar rash (60.3%). Leucopenia, fever, hair loss and proteinuria were observed in approximately half of the patients. Anaemia was found in 44.3% but only 9.9% had haemolytic anaemia. Photosensitive rash was seen in 43% of patients. Approximately one-third of the patients had serositis and mouth ulcers, 30.5 and 27.2% respectively. Vasculitis was observed in 19.2% of patients. Neuropsychiatric manifestations (15.9%), discoid lupus lesions (12.6%), and brain infarcts (13.2%) were infrequent. Subacute cutaneous lupus (6%) was also uncommon. Anti-nuclear antibodies were detected in 98%, anti-double stranded DNA antibodies in 88.7%, anti-Sm antibodies in 19.7%, anti-RNP in 40.4%, anti-Ro antibodies in 52.3% and anti-La antibodies in 19.8%. Anti-cardiolipin IgM and IgG were detected in 25.3 and 22.4%, respectively. This study suggests that Arabs with SLE residing in Dubai have comparable clinical features to their counterparts in other Arab countries and Western countries. The high prevalence of positive anti-Ro antibodies among our Arab patients probably reflects a character, that is, commonly seen in SLE patients of Middle East origin. Lupus (2008) 17, 62-66.
引用
收藏
页码:62 / 66
页数:5
相关论文
共 32 条
[1]   Mucocutaneous disease in Arabs with systemic lupus erythematosus: Clinical expression and relevance to autoantibodies [J].
Al-Attia, HM ;
Al Ahmed, YH .
LUPUS, 1998, 7 (08) :535-539
[2]   Systemic lupus erythematosus in Kuwait - hospital based study [J].
Al-Jarallah, K ;
Al-Awadi, A ;
Siddiqui, H ;
Al-Salim, I ;
Shehab, D ;
Umamaheswaran, I ;
Gaurer, S ;
Al-Saied, K ;
Kumar, R ;
Malaviya, AN .
LUPUS, 1998, 7 (07) :434-438
[3]   Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman [J].
Al-Maini, MH ;
El-Ageb, EM ;
Al-Wahaibi, SS ;
Al-Farsi, Y ;
Richens, ER .
RHEUMATOLOGY INTERNATIONAL, 2003, 23 (04) :186-191
[4]  
Alarcón GS, 1998, ARTHRITIS RHEUM-US, V41, P1173, DOI 10.1002/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO
[5]  
2-A
[6]   Systemic lupus erythematosus in three ethnic groups:: III A comparison of characteristics early in the natural history of the LUMINA cohort [J].
Alarcón, GS ;
Friedman, AW ;
Straaton, KV ;
Moulds, JM ;
Lisse, J ;
Bastian, HM ;
McGwin, G ;
Bartolucci, AA ;
Roseman, JM ;
Reveille, JD .
LUPUS, 1999, 8 (03) :197-209
[7]   PRELIMINARY CLASSIFICATION CRITERIA FOR THE ANTIPHOSPHOLIPID SYNDROME WITHIN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
ALARCONSEGOVIA, D ;
PEREZVAZQUEZ, ME ;
VILLA, AR ;
DRENKARD, C ;
CABIEDES, J .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1992, 21 (05) :275-286
[8]   CHARACTERIZATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN PATIENTS IN UAE [J].
ALATTIA, HM ;
GEORGE, S .
CLINICAL RHEUMATOLOGY, 1995, 14 (02) :171-175
[9]   Clinicolaboratory profile of 33 Arabs with systemic lupus erythematosus [J].
AlAttia, HM .
POSTGRADUATE MEDICAL JOURNAL, 1996, 72 (853) :677-679
[10]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN SAUDI PATIENTS [J].
ALBALLA, SR .
CLINICAL RHEUMATOLOGY, 1995, 14 (03) :342-346